Trademark Details For RETINOSTAT (Serial Number 78260879)

Home
Print

RETINOSTAT

Rank
Global Trademark Influence Ranking
3398

word.basic_information

Serial Number United States - USPTO 78260879

Registration Number 3372819

Mark

RETINOSTAT

Filing Date Jun-11-2003

Status

Dead

Attorney Name

Roberta S. Bren

TTAB

Action Tags

word.owners (1)

OXFORD BIOMEDICA PLC

Mark Information

Color(s) Claimed:
Color is not claimed as a feature of the mark.

word.classifications (3)

001Chemicals

U.S Class(es): 001, 005, 006, 010, 026, 046

Class Status: Sec. 8 - Entire Registration

Chemical and biochemical products for use in gene delivery technology, namely, enzymes; chemical products for in-vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology;

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Sec. 8 - Entire Registration

Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of [ blood disorders, cancers, diseases of the nervous system, ] macular degeneration, diabetic retinopathy, [ diabetes, inflammatory and auto-immune diseases, vascular disorders, ] disorders arising from improper vascularisation and single gene disorders; pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies, vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy [ and angiogenesis; ] instruments and apparatus for the administration of gene and [ antibody-based ] therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes;

042Computer, scientific and legal

U.S Class(es): 100, 101

Class Status: Sec. 8 - Entire Registration

Scientific and medical research and development; [ engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; ] advisory services relating to the research and development of gene therapy; consultation services in the fields of medical and scientific research in the field of professional gene therapy [; medical research and development in the field of vector production technologies ];

Correspondences

Name	Roberta S. Bren
Address	MUNCY, GEISSLER, OLDS & LOWE, P.C. 4000 Legato Road, Suite 310 Fairfax VA 22033

Prosecution History

USPTO

Date	Description	Code
Aug-23-2019	CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9	CAEXO
Mar-23-2017	REGISTERED - SEC. 7 REQUEST ABANDONED	PRA7O
Jan-22-2017	COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED	REM2E
Mar-14-2016	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	ARAAI
Mar-14-2016	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	REAPI
Mar-04-2014	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	APREA
Mar-04-2014	POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED 1. Offc Action Outgoing2014-03-04	PRANO
Feb-28-2014	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	APREA
Feb-27-2014	REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD	CORV6
Feb-26-2014	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	APREA
Feb-10-2014	TEAS SECTION 7 REQUEST RECEIVED	ES7RI
Feb-10-2014	TEAS CHANGE OF CORRESPONDENCE RECEIVED	TCCAI
Feb-03-2014	NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED	NA85E
Feb-03-2014	REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.	C15AO
Jan-22-2014	REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED	815FI
Feb-03-2014	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	APREA
Jan-22-2014	TEAS SECTION 8 & 15 RECEIVED	E815I
Jan-22-2014	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	ARAAI
Jan-22-2014	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	REAPI
Jan-22-2008	REGISTERED-PRINCIPAL REGISTER	R.PRA
Dec-19-2007	1(B) BASIS DELETED; PROCEED TO REGISTRATION	DP1BI
Jul-18-2007	NOTICE OF ALLOWANCE CANCELLED	IUCNS
Jul-18-2007	TEAS DELETE 1(B) BASIS RECEIVED	D1BRI
Jul-03-2007	NOA MAILED - SOU REQUIRED FROM APPLICANT	NOAMO
Apr-10-2007	PUBLISHED FOR OPPOSITION	PUBOA
Mar-21-2007	NOTICE OF PUBLICATION	NPUBO
Feb-26-2007	LAW OFFICE PUBLICATION REVIEW COMPLETED	PREVO
Feb-26-2007	ASSIGNED TO LIE	ALIEA
Jan-22-2007	APPROVED FOR PUB - PRINCIPAL REGISTER	CNSAP
Jan-19-2007	TEAS/EMAIL CORRESPONDENCE ENTERED	TEMEI
Jan-18-2007	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jan-18-2007	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Jul-21-2006	NON-FINAL ACTION MAILED 1. Offc Action Outgoing2006-07-20	CNRTO
Jul-20-2006	NON-FINAL ACTION WRITTEN 1. Offc Action Outgoing2006-07-20	CNRTR
Jul-20-2006	ASSIGNED TO EXAMINER	DOCKD
Jul-13-2006	PREVIOUS ALLOWANCE COUNT WITHDRAWN	ZZZXZ
Jul-13-2006	TEAS/EMAIL CORRESPONDENCE ENTERED	TEMEI
Jul-11-2006	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jul-11-2006	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Jun-02-2006	WITHDRAWN FROM PUB - OG REVIEW QUERY	PBCRZ
May-12-2006	LAW OFFICE PUBLICATION REVIEW COMPLETED	PREVO
May-05-2006	ASSIGNED TO LIE	ALIEA
May-01-2006	APPROVED FOR PUB - PRINCIPAL REGISTER	CNSAP
Apr-27-2006	TEAS/EMAIL CORRESPONDENCE ENTERED	TEMEI
Apr-20-2006	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Apr-21-2006	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Apr-20-2006	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Feb-28-2006	NON-FINAL ACTION MAILED 1. Offc Action Outgoing2006-02-28	CNRTO
Feb-28-2006	NON-FINAL ACTION WRITTEN 1. Offc Action Outgoing2006-02-28	CNRTR
Feb-21-2006	PREVIOUS ALLOWANCE COUNT WITHDRAWN	ZZZXZ
Feb-09-2006	WITHDRAWN FROM PUB - OG REVIEW QUERY	PBCRZ
Jan-20-2006	LAW OFFICE PUBLICATION REVIEW COMPLETED	PREVO
Jan-13-2006	ASSIGNED TO LIE	ALIEA
Jan-09-2006	APPROVED FOR PUB - PRINCIPAL REGISTER	CNSAP
Jan-07-2006	TEAS/EMAIL CORRESPONDENCE ENTERED	TEMEI
Jan-04-2006	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jan-04-2006	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Oct-26-2005	CORRESPONDENCE MAILED	CRMLO
Oct-26-2005	PRIORITY ACTION WRITTEN	CPRAR
Oct-03-2005	AMENDMENT FROM APPLICANT ENTERED	ACECI
Sep-19-2005	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Sep-19-2005	PAPER RECEIVED	MAILI
Aug-04-2005	LETTER OF SUSPENSION MAILED	CNSLS
Aug-04-2005	SUSPENSION LETTER WRITTEN	CNSLR
Aug-03-2005	AMENDMENT FROM APPLICANT ENTERED	ACECI
Jul-22-2005	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jul-22-2005	PAPER RECEIVED	MAILI
Jan-31-2005	FAX SENT	FAXXO
Jan-28-2005	TEAS CHANGE OF CORRESPONDENCE RECEIVED	TCCAI
Jan-19-2005	INQUIRY TO SUSPENSION E-MAILED	GNSIS
Jan-19-2005	SUSPENSION INQUIRY WRITTEN	CNSIR
Jul-19-2004	LETTER OF SUSPENSION E-MAILED	GNSLS
Jun-21-2004	TEAS/EMAIL CORRESPONDENCE ENTERED	TEMEI
Jun-21-2004	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jun-21-2004	AMENDMENT FROM APPLICANT ENTERED	ACECI
Jun-21-2004	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jun-21-2004	TEAS RESPONSE TO OFFICE ACTION RECEIVED	TROAI
Dec-22-2003	NON-FINAL ACTION E-MAILED	GNRTF
Dec-18-2003	ASSIGNED TO EXAMINER	DOCKD
Jul-02-2003	APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED	AMPXO
Jul-02-2003	CORRESPONDENCE RECEIVED IN LAW OFFICE	CRFAI
Jul-02-2003	TEAS VOLUNTARY AMENDMENT RECEIVED	PARII

Solutions

Products

Product Features

FAQ

Client Testimonials

Insights

Analytics

Huski Analytics

Industry Trends

AI Concepts & Trends

Huski Blog

Huski AI Community Events

Our Company

Our Technology

Huski AI in the News

Trademark Details For RETINOSTAT (Serial Number 78260879)

Correspondences

Prosecution History

About

Trademark Ranking

Directories

Privacy & Security

Follow us

Others